{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-003896","form_type":"8-K","ticker":"VNRX","cik":"0000093314","company_name":"VOLITIONRX LTD","filed_at":"2024-06-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:22.544423+00:00","generated_at":"2026-06-01T01:18:35.381691+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"VolitionRx mid-year: Vet test in 15 countries, $23M milestones, human license target H2 2024","bullets":["Nu.Q Vet Cancer Test now available in 15 countries via Antech, IDEXX, Fujifilm; aiming to triple 2023 test sales of 58,000.","Received $23M in upfront and milestone payments from Heska (Antech) for veterinary test.","Preparing data rooms for Nu.Q NETs, Nu.Q Lung, and Capture-PCR technologies; first human licensing deal targeted in H2 2024.","Capture-PCR method for direct ctDNA detection submitted for peer review July 2024; early-stage cancer discrimination demonstrated.","Active commercial discussions with major liquid biopsy, IVD, and oncology players."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-003896","json":"https://secwatch.observer/filing/0001477932-24-003896.json","markdown":"https://secwatch.observer/filing/0001477932-24-003896.md","text":"https://secwatch.observer/filing/0001477932-24-003896.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/93314/000147793224003896/0001477932-24-003896-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/93314/000147793224003896/vnrx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T01:18:35.381691+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}